Medicare Enrolled

Dr. Daniel Su, M.D.

Ophthalmology · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1245 WILSHIRE BLVD STE 380, Los Angeles, CA 90017
2134838810
In practice since 2013 (13 years)
NPI: 1508109133 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Su from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Su? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Su

Dr. Daniel Su is an ophthalmology specialist in Los Angeles, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Su performed 18,063 Medicare services across 2,769 unique beneficiaries.

Between the years covered by Open Payments, Dr. Su received a total of $18,613 from 20 pharmaceutical and/or device companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Su is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 6% volume in CA $18,613 industry payments

Medicare Practice Summary

Medicare Utilization ↗
18,063
Medicare services
Top 6% in CA for ophthalmology
2,769
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,389 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
9,780 $28 $85
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
2,076 $218 $700
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,786 $34 $150
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,494 $106 $300
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
886 $108 $770
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
500 $12 $170
Aflibercept eye injection (Eylea) 480 $679 $2,500
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
270 $120 $400
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
197 $127 $300
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
116 $1,238 $3,978
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
108 $33 $115
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
92 $76 $200
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
77 $19 $170
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
41 $38 $200
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
36 $128 $275
Laser vitreolysis
A laser procedure used to destroy fluid in the vitreous of the eye, located between the lens and the retina.
19 $823 $6,200
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
17 $599 $5,500
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
17 $289 $1,900
Prosthetic lens exchange
Surgical removal of an existing artificial lens and replacement with a new one.
16 $593 $2,000
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
16 $55 $200
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
14 $192 $1,650
New patient office visit, complex (60-74 min) 14 $191 $375
Aspiration of lens material by fragmenting and aspiration 11 $377 $2,700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,613
Total received (2018-2024)
Avg $2,659/year across 7 years
Top 10% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
74
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,511 (51.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,042 (32.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,060 (16.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,060
2023
$4,983
2022
$580
2021
$444
2020
$71
2019
$406
2018
$1,069

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$6,277
Genentech USA, Inc.
$2,144
Regeneron Healthcare Solutions, Inc.
$2,097
Cardinal Health 110 LLC
$150
Sandoz Inc.
$138
Apellis Pharmaceuticals, Inc.
$121
Alimera Sciences, Inc.
$106
AngioDynamics, Inc.
$27
Top 3 companies account for 95.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$6,356
Regeneron Healthcare Solutions, Inc.
$6,322
Genentech USA, Inc.
$2,187
Regeneron Pharmaceuticals, Inc.
$1,858
Alimera Sciences, Inc.
$405
Alcon Vision LLC
$274
Apellis Pharmaceuticals, Inc.
$232
EyePoint Pharmaceuticals US, Inc.
$159
Cardinal Health 110 LLC
$150
Sandoz Inc.
$138
Allergan Inc.
$136
Alcon Laboratories Inc
$129
Mallinckrodt Hospital Products Inc.
$93
AbbVie Inc.
$42
Biogen, Inc.
$28
AngioDynamics, Inc.
$27
Novartis Pharmaceuticals Corporation
$23
Carl Zeiss Meditec AG
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Allergan, Inc.
$17
Top 3 companies account for 79.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Cequa · Cimerli · Constellation · DEXYCU · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · Iluvien · Lucentis · NANOKNIFE · NGENUITY · None Specified · OZURDEX · SUSVIMO · Syfovre · Vabysmo · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (51%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for ophthalmology in CA.

Looking for an ophthalmology specialist in Los Angeles?
Compare ophthalmologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
788
Per 100K population
8.0
County median income
$87,760
Nearest hospital
PIH HEALTH GOOD SAMARITAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Su is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with consulting-driven industry engagement in the top 10% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Su experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Su performed 9,780 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Su receive payments from pharmaceutical companies?
Yes. Dr. Su received a total of $18,613 from 20 companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Su's costs compare to other ophthalmologists in Los Angeles?
Dr. Su's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Su) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →